Altamira TherapeuticsCYTOF
13F holders, Q2 2026 (June 30)1holders
0new positions
0sold out
$0.00avg. 13F price*
At the end of Q2 2026, 1 institutions reported holding Altamira Therapeutics Ltd. (CYTOF) in their 13F filings, unchanged from Q1 2026. 0 opened new positions and 0 sold out. The largest holder was LRI Investments, LLC ($0).
- Company
- Altamira Therapeutics Ltd.
- CUSIP
- G0360L134
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| LRI Investments, LLC | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is CYTOF's weight in each manager's 13F, not the share of Altamira Therapeutics Ltd. the manager owns.